Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for EW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -0.50M
March 31, 2026 452.90M
December 31, 2025 8.30M
September 30, 2025 504.00M
June 30, 2025 -51.70M
March 31, 2025 258.70M
December 31, 2024 -28.50M
September 30, 2024 966.50M
June 30, 2024 103.80M
March 31, 2024 -61.90M
December 31, 2023 415.20M
September 30, 2023 140.40M
June 30, 2023 -53.30M
March 31, 2023 207.40M
December 31, 2022 838.50M
September 30, 2022 68.00M
June 30, 2022 306.10M
March 31, 2022 368.10M
December 31, 2021 62.60M
September 30, 2021 -37.10M
June 30, 2021 57.70M
March 31, 2021 271.00M
December 31, 2020 -36.80M
September 30, 2020 -34.70M
June 30, 2020 -29.30M
Date Value
March 31, 2020 585.70M
December 31, 2019 -35.00M
September 30, 2019 -37.70M
June 30, 2019 214.80M
March 31, 2019 -39.30M
December 31, 2018 244.30M
September 30, 2018 138.10M
June 30, 2018 308.60M
March 31, 2018 -42.50M
December 31, 2017 228.80M
September 30, 2017 -21.80M
June 30, 2017 28.20M
March 31, 2017 414.30M
December 31, 2016 260.80M
September 30, 2016 -37.90M
June 30, 2016 11.50M
March 31, 2016 324.60M
December 31, 2015 72.80M
September 30, 2015 -17.30M
June 30, 2015 59.90M
March 31, 2015 77.50M
December 31, 2014 -41.80M
September 30, 2014 -38.30M
June 30, 2014 -18.10M
March 31, 2014 285.80M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Stryker Corp. 0.00
Intuitive Surgical, Inc. 254.70M
Abbott Laboratories 1.042B
Boston Scientific Corp. 1.995B
Zimmer Biomet Holdings, Inc. 250.60M